{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:20:14Z","timestamp":1793654414143,"version":"4.5.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The project of Tutorial System of Medical Undergraduate in Lab Teaching & Management Center in Chongqing Medical University","award":["LTMCMTS202001"],"award-info":[{"award-number":["LTMCMTS202001"]}],"id":[{"id":"https:\/\/ror.org\/017z00e58","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Proteinuria is one of the common manifestations of patients with preeclampsia (PE), but whether the severity of proteinuria is related to the pregnancy outcome of patients with preeclampsia remains controversial. The present study aimed to determine the relationship between 24-h proteinuria and adverse outcomes in patients with preeclampsia.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n The present retrospective study included 329 pregnant women in Chongqing, China. Patients were divided into PE group and non-PE group. PE group was stratified into three subgroups based on the level of 24-h proteinuria. Correlation analysis was used to analyze the correlation between biochemical indexes and adverse pregnancy outcome, and Logistic regression analysis was used to analyze the risk factors of adverse pregnancy outcome. The receiver operating characteristic curve (ROC) was used to evaluate the ability of 24-h urinary protein to distinguish the adverse pregnancy outcome in patients with preeclampsia.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n (1)<\/jats:bold>\n Between PE and non-PE group, cesarean section rate in PE group was significantly higher than that in non-PE group (84.4% vs. 25.9%,\n p<\/jats:italic>\n \u2009<\u2009\u00a00.001). Laboratory findings such as uric acid and creatinine level in PE group were higher than those in non-PE group.\n (2)<\/jats:bold>\n Among mild (proteinuria <\u20090.3\u2009g\/24\u2009h), moderate (0.3\u2009g\/24\u2009h \u2266 proteinuria <\u20092\u2009g\/24\u2009h) and massive (proteinuria \u2267 2\u2009g\/24\u2009h) groups, the frequencies of induced labor (\n p<\/jats:italic>\n \u2009=\u20090.006) and stillbirth (\n p<\/jats:italic>\n \u2009=\u20090.002) increased with the increase of 24-h proteinuria.\n (3)<\/jats:bold>\n Adverse outcomes were positively correlated with 24-h proteinuria (adverse maternal outcomes:\n r<\/jats:italic>\n \u2009=\u20090.239,\n p<\/jats:italic>\n \u2009=\u20090.002; adverse fetal outcomes:\n r<\/jats:italic>\n \u2009=\u20090.336,\n p<\/jats:italic>\n \u2009<\u2009\u00a00.001).\n (4)<\/jats:bold>\n The best 24-h proteinuria cutoff values to determine stillbirth, premature and fetal distress were 3965.0\u2009mg\/24\u2009h, 984.75\u2009mg\/24\u2009h and 1503.85\u2009mg\/24\u2009h and their odds ratio (95% confidence interval) were 12.46 (3.46\u201344.88), 2.48 (1.15\u20135.37) and 10.02 (2.14\u201346.80), respectively.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The severity of 24-h proteinuia may forecast adverse outcomes in women with preeclampsia. We suggest proteinuria should be retained as one of the monitoring indexes in patients with preeclampsia.<\/jats:p>\n <\/jats:sec>\n \n Trial registration<\/jats:title>\n Retrospectively registered. (LTMCMTS202001).<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/s12958-021-00751-y","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:02:26Z","timestamp":1620968546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Tingting","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4391-2432","authenticated-orcid":false,"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"issue":"4","key":"751_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.trsl.2014.10.006","volume":"165","author":"S Lin","year":"2015","unstructured":"Lin S, Leonard D, Co MA, Mukhopadhyay D, Giri B, Perge L, et al. Pre-eclampsia has an adverse impact on maternal and fetal health. Transl Res. 2015;165(4):449\u201363. https:\/\/doi.org\/10.1016\/j.trsl.2014.10.006.","journal-title":"Transl Res"},{"key":"751_CR2","doi-asserted-by":"publisher","unstructured":"Fishel Bartal M, Lindheimer MD, Sibai BM. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance. Am J Obstet Gynecol. 2020. https:\/\/doi.org\/10.1016\/j.ajog.2020.08.108.","DOI":"10.1016\/j.ajog.2020.08.108"},{"issue":"11","key":"751_CR3","first-page":"5162","volume":"28","author":"J Cai","year":"2015","unstructured":"Cai J, Wang T, Li M, Cheng X, Zhang Y. Isolated proteinuria in Chinese pregnant women with pre-eclampsia: results of retrospective observational study. Biomed Res. 2015;28(11):5162\u20136.","journal-title":"Biomed Res"},{"issue":"11","key":"751_CR4","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.3109\/14767058.2015.1061497","volume":"29","author":"A Ekiz","year":"2016","unstructured":"Ekiz A, Kaya B, Polat I, Avci ME, Ozkose B, Kicik Caliskan R, et al. The outcome of pregnancy with new onset proteinuria without hypertension: retrospective observational study. J Matern Fetal Neonatal Med. 2016;29(11):1765\u20139. https:\/\/doi.org\/10.3109\/14767058.2015.1061497.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"751_CR5","doi-asserted-by":"publisher","unstructured":"Mateus J, Newman R, Sibai BM, et al. Massive Urinary Protein Excretion Associated with Greater Neonatal Risk in Preeclampsia. AJP Rep. 2017. https:\/\/doi.org\/10.1055\/s-0037-1601866.","DOI":"10.1055\/s-0037-1601866"},{"key":"751_CR6","doi-asserted-by":"publisher","unstructured":"Pregnancy Hypertension Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the Diagnosis and Treatment of Hypertensive Disorders Complicating Pregnancy (2012). Chin J Obstetrics Gynecol. 2012. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567x.2012.06.018.","DOI":"10.3760\/cma.j.issn.0529-567x.2012.06.018"},{"issue":"5","key":"751_CR7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","volume":"122","author":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy","year":"2013","unstructured":"American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122(5):1122\u201331.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"751_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/AOG.0000000000003018","volume":"133","author":"ACOG Practice Bulletin No","year":"2019","unstructured":"Practice Bulletin No ACOG. 202: gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133(1):1. https:\/\/doi.org\/10.1097\/AOG.0000000000003018 PMID: 30575675.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"751_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/jp.2015.138","volume":"36","author":"S Shinar","year":"2016","unstructured":"Shinar S, Asher-Landsberg J, Schwartz A, Ram-Weiner M, Kupferminc MJ, Many A. Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria. J Perinatol. 2016;36(1):25\u20139. https:\/\/doi.org\/10.1038\/jp.2015.138.","journal-title":"J Perinatol"},{"issue":"2","key":"751_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.12891\/ceog16692014","volume":"41","author":"Z Bouzari","year":"2014","unstructured":"Bouzari Z, Javadiankutenai M, Darzi A, Barat S. Does proteinura in preeclampsia have enough value to predict pregnancy outcome? Clin Exp Obstet Gynecol. 2014;41(2):163\u20138.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"003","key":"751_CR11","first-page":"161","volume":"019","author":"Pregnancy Hypertension Group of Obstetrics and Gynecology Branch of Chinese Medical Association","year":"2016","unstructured":"Pregnancy Hypertension Group of Obstetrics and Gynecology Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of hypertensive disorders complicating pregnancy (2015). Chin J Obstet Gynecol. 2016;019(003):161\u20139.","journal-title":"Chin J Obstet Gynecol"},{"issue":"2","key":"751_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3109\/10641955.2015.1130832","volume":"35","author":"M Rezk","year":"2016","unstructured":"Rezk M, Abo-Elnasr M, Al Halaby A, Zahran A, Badr H. Maternal and fetal outcome in women with gestational hypertension in comparison to gestational proteinuria: a 3-year observational study. Hypertens Pregnancy. 2016;35(2):181\u20138. https:\/\/doi.org\/10.3109\/10641955.2015.1130832.","journal-title":"Hypertens Pregnancy"},{"issue":"10","key":"751_CR13","doi-asserted-by":"publisher","first-page":"e76083","DOI":"10.1371\/journal.pone.0076083","volume":"8","author":"B Kate","year":"2013","unstructured":"Kate B, Carlos E, Poli-de-Figueiredo P, et al. Association of proteinuria threshold in pre-eclampsia with maternal and perinatal outcomes: a nested case control cohort of high risk women. PLoS One. 2013;8(10):e76083. https:\/\/doi.org\/10.1371\/journal.pone.0076083.","journal-title":"PLoS One"},{"issue":"4","key":"751_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1440-1681.2009.05334.x","volume":"37","author":"CE Thornton","year":"2010","unstructured":"Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Role of proteinuria in defining pre-eclampsia: Clinical outcomes for women and babies. Clin Exp Pharmacol Physiol. 2010;37(4):466\u201370. https:\/\/doi.org\/10.1111\/j.1440-1681.2009.05334.x.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"751_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"A Brown Mark","year":"2018","unstructured":"Brown Mark A, Magee Laura A, Kenny Louise C, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international Practice. Hypertension. 2018;72(1):24\u201343. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10803.","journal-title":"Hypertension."},{"issue":"2","key":"751_CR16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/HJH.0b013e3282f1a953","volume":"26","author":"CS Homer","year":"2008","unstructured":"Homer CS, Brown MA, Mangos G, Davis GK. Non-proteinuric pre-eclampsia: a novel risk indicator in women with gestational hypertension. J Hypertens. 2008;26(2):295\u2013302. https:\/\/doi.org\/10.1097\/HJH.0b013e3282f1a953.","journal-title":"J Hypertens"},{"issue":"17","key":"751_CR17","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.3390\/ijms20174246","volume":"20","author":"T Tomimatsu","year":"2019","unstructured":"Tomimatsu T, Mimura K, Matsuzaki S, Endo M, Kumasawa K, Kimura T. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental Antiangiogenic factors. Int J Mol Sci. 2019;20(17):4246. https:\/\/doi.org\/10.3390\/ijms20174246.","journal-title":"Int J Mol Sci"},{"issue":"004","key":"751_CR18","first-page":"197","volume":"24","author":"Z Yang","year":"2008","unstructured":"Yang Z. Etiology and Management of Oligohydramnios. J Pract Obstet Gynecol. 2008;24(004):197\u20139.","journal-title":"J Pract Obstet Gynecol"},{"issue":"1","key":"751_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1067\/mob.2003.84","volume":"188","author":"MG Newman","year":"2003","unstructured":"Newman MG, Robichaux AG, Stedman CM, Jaekle RK, Fontenot MT, Dotson T, et al. Perinatal outcomes in preeclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol. 2003;188(1):264\u20138. https:\/\/doi.org\/10.1067\/mob.2003.84.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"751_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/10641950903454564","volume":"30","author":"SH Martins-Costa","year":"2011","unstructured":"Martins-Costa SH, Vettorazzi J, Val\u00e9rio E, Maurmman C, Benevides G, Hemessath M, et al. Protein creatinine ratio in random urine sample of hypertensive pregnant women: maternal and perinatal outcomes. Hypertens Pregnancy. 2011;30(3):331\u20137. https:\/\/doi.org\/10.3109\/10641950903454564.","journal-title":"Hypertens Pregnancy."},{"key":"751_CR21","doi-asserted-by":"publisher","first-page":"431837","DOI":"10.1155\/2014\/431837","volume":"2014","author":"A Kumari","year":"2014","unstructured":"Kumari A, Chakrawarty A, Singh A, Singh R. Maternofoetal complications and their association with proteinuria in a tertiary care hospital of a developing country. J Pregnancy. 2014;2014:431837.","journal-title":"J Pregnancy"},{"issue":"3","key":"751_CR22","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1471-0528.2004.00395.x","volume":"112","author":"P Chan","year":"2005","unstructured":"Chan P, Brown M, Simpson JM, Davis G. Proteinuria in pre-eclampsia: how much matters? BJOG. 2005;112(3):280\u20135. https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00395.x.","journal-title":"BJOG."},{"key":"751_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.preghy.2019.12.013","volume":"19","author":"M Morikawa","year":"2020","unstructured":"Morikawa M, Mayama M, Saito Y, Nakagawa K, Umazume T, Chiba K, et al. Severe proteinuria as a parameter of worse perinatal\/neonatal outcomes in women with preeclampsia. Pregnancy Hypertens. 2020;19:119\u201326. https:\/\/doi.org\/10.1016\/j.preghy.2019.12.013.","journal-title":"Pregnancy Hypertens"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-021-00751-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-021-00751-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T05:07:43Z","timestamp":1672117663000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-021-00751-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["751"],"URL":"https:\/\/doi.org\/10.1186\/s12958-021-00751-y","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"assertion":[{"value":"10 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No patient consent was required for this retrospective cohort study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the manuscript and consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}